Biopsy Needle Market Size

  • Report ID: 6404
  • Published Date: Sep 09, 2024
  • Report Format: PDF, PPT

Biopsy Needle Market Size

Biopsy Needle Market size is estimated at USD 1.7 billion in 2024 and is likely to exceed USD 3.8 billion by the end of 2037, expanding at over 7.1% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of biopsy needle is evaluated at USD 1.9 billion.

The biopsy needle market is rapidly expanding due to the rising prevalence of various chronic diseases. Biopsy needles play a crucial role in the healthcare sector, enabling healthcare professionals to gain accurate diagnosis results and develop effective treatment schedules. With advancements in technology and continuous research and development in this domain, the focus is shifting toward minimally invasive procedures, expanding healthcare infrastructure, and result-oriented outcomes. Furthermore, automated and image-guided biopsy needles induce market demand enhancing precision and reducing tissue trauma. This market emphasizes needle designing, manufacturing, and distribution to conduct biopsy procedures for the end users with an effortless and time-saving approach leading to improved diagnostics accuracy and reliability.


Biopsy Needle Market Overview
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 6404
  • Published Date: Sep 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the biopsy needle market was over USD 1.7 billion.

The market size of the biopsy needle landscape is projected to surpass USD 3.8 billion by the end of 2037 expanding at a CAGR of 7.1% during the forecast period i.e., between 2025-2037.

The major players in the market are Becton, Medtronic Plc, Cardinal Health, Hologic Inc., Olympus Corporation, Argon Medical Devices Inc., Devicor Medical Products, Inc., Cook Group Incorporated, Boston Scientific Corporation, FUJIFILM Holdings Corporation, Dickinson and Company, and INRAD, Inc.

In terms of product, the biopsy needle guns segment is anticipated to garner the largest market share of 64.1% by 2037 and display significant growth opportunities during 2025-2037.

The market in North America is projected to hold the largest revenue share of 41.2% by the end of 2037 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample